InvestorBrandNetwork
Bio
The InvestorBrandNetwork (IBN) is comprised of 40+ investor focused brands and offers a comprehensive suite of corporate communications solutions that reach new audiences on an ongoing focus basis. Full disclaimers: http://bit.ly/2S7w1sC
Stories (752/0)
Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Investee Company, PowerTap, Hires NASA-Based Firm to Engineer Hydrogen Production Unit
Hydrogen fuel cell vehicle market forecasted for CAGR of 66.9% from 2019 to 2026 and projected to reach $42 billion by 2026, according to Allied Market Research (https://nnw.fm/IOAUD) PowerTap plans to install an initial 500 hydrogen filling stations in California and an additional 500 hydrogen filling stations over next three to five years in other parts of the USA. Clean energy expert Greg Nuttall appointed to the PowerTap advisory board.
By InvestorBrandNetwork3 years ago in Trader
Friendable Inc. (FDBL) Fan Pass Platform Reaches 50 Artist-Channel Milestone, surpassing 70 total live Artist-Channels
New November artist sign-ups bring almost 500,000 fans, followers with them FDBL CEO notes “significant achievements at almost every turn as we build on the initial wave of response to the Fan Pass offering”
By InvestorBrandNetwork3 years ago in Trader
GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Offers Strengths Investors Look For During Uncertain Times
Project quality is jurisdiction–related with transparent permitting, well-developed infrastructure being critical GOH operates assets in Chile and Canada, led by experienced management team
By InvestorBrandNetwork3 years ago in Trader
Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Produces Rare Earth Carbonate Concentrate, a Milestone Moment for US
The high-purity concentrate is ready to send to separation plant for final acceptance test work. Company used existing infrastructure and technologies, thereby avoiding years of permitting and development, as well as need for significant capital.
By InvestorBrandNetwork3 years ago in Trader
Net Element (NETE) Buoyed by Investor Interest Within EV Sector as Tesla Gets Included in S&P500
Investor interest in the sector has spilled over to Net Element, with one the world’s largest asset managers, Renaissance Technologies taking a 3.2% stake in the company in the third quarter A future combined Net Element-Mullen Technologies plans to begin marketing its initial vehicle model, the Dragonfly K50 in 2Q2021.
By InvestorBrandNetwork3 years ago in Trader
Pure Extracts Technologies Corp. (CSE: PULL) Issues Corporate Update Detailing Operations, Product Strategy and Market Conditions
Pure Extracts’ “Pure Pulls” and “Pure Mushrooms’” branded products expected to be available by end of Q1 2021 Global cannabis extract market size expected to reach USD$28.5 billion by 2027 with CAGR of 16.6%; global functional mushrooms market expected to reach USD$34.3 billion by 2024 with CAGR of 8%
By InvestorBrandNetwork3 years ago in Potent
Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Releases Q3 Financial Results, Corporate Highlights
Key quarter highlights include becoming debt-free, progress on rare earth elements (“REEs”) CEO reports company making “significant strides in the last quarter on our uranium, rare earths and other initiatives”
By InvestorBrandNetwork3 years ago in Trader
GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Leverages Key Strengths Essential in Today’s Mining Sector
Elliott finds certain jurisdictions, including Canada and South America, compelling mining locations Led by industry-seasoned professionals and operating in Canada and Chile, GoldHaven Resources appears well positioned to respond to mining investors’ demands
By InvestorBrandNetwork3 years ago in Trader
CNS Pharmaceuticals (NASDAQ: CNSP) Advances Brain Cancer Drug Candidate and Sponsors Annual SNO Conference
Since another company conducted Phase 1 safety trials for Berubicin 14 years ago, one patient has survived cancer-free while two others saw reductions in tumor size of up to 80 percent The Phase 2 trials will build on the Phase 1 results, conducting targeted testing that offers side-by-side comparison between Berubicin and chemotherapy drug lomustine in real time beginning next year The company is also preparing with WPD to conduct the first Phase I trials of Berubicin in children in Europe CNS Pharmaceuticals officers recently participated virtually in the annual Society for Neuro-Oncology (“SNO”) Scientific Meeting and Education Day to promote their work and discuss the progress of clinical trials
By InvestorBrandNetwork3 years ago in Trader